Braf-mutant metastatic non–small-cell lung cancer: Real world data from the Italian biomarker atlas database
These data confirm the efficacy and safety of first line D/T in BRAF V600E-mutated pts in the real-world setting consistently with prior studies, suggesting a differential activity among key clinical-molecular subgroups.
Authors
- Gabriele Minuti (ORCID: https://orcid.org/0000-0003-2363-0446)
- Cristina Zannori
- Lorenzo Calvetti (ORCID: https://orcid.org/0000-0002-9135-8715)
- Luca Toschi (ORCID: https://orcid.org/0000-0002-4023-7542)
- Diego Signorelli (ORCID: https://orcid.org/0000-0001-5507-7820)
- Sara Pilotto (ORCID: https://orcid.org/0000-0003-2229-4874)
- Cinzia Ortega (ORCID: https://orcid.org/0000-0003-2628-7671)
- Rita Chiari (ORCID: https://orcid.org/0000-0002-7649-273X)
- Fabrizio Citarella (ORCID: https://orcid.org/0000-0003-3096-4452)
- Stefania Gori
- Lucia Anna Muscarella (ORCID: https://orcid.org/0000-0002-1866-8151)
- Giulia Meoni (ORCID: https://orcid.org/0000-0002-2683-1123)
- Pamela Pizzutilo
- Diego Cortinovis (ORCID: https://orcid.org/0000-0001-7611-7369)
- Maria Lucia Reale (ORCID: https://orcid.org/0000-0001-9210-5149)
- Serena Ricciardi (ORCID: https://orcid.org/0000-0001-5401-4836)
- Giacomo Pelizzari (ORCID: https://orcid.org/0000-0003-1224-9906)
- Brigida Stanzione (ORCID: https://orcid.org/0000-0002-0475-7399)
- Daniele Pignataro (ORCID: https://orcid.org/0000-0001-7561-622X)
- E. Bria
- diana giannarelli
- Claudio Sini
- Carlo Genova (ORCID: https://orcid.org/0000-0003-3690-8582)
- Giulia Pasello (ORCID: https://orcid.org/0000-0002-8741-6038)
- L Buffoni (ORCID: https://orcid.org/0000-0001-7174-5374)
- Alberto Pavan (ORCID: https://orcid.org/0000-0003-4695-0100)
- Concetta Sergi (ORCID: https://orcid.org/0000-0003-0814-3148)
- Umberto Malapelle
- Hector Soto Parra
- Antonello Veccia
- Lorenzo Antonuzzo
- Anna Bettin
- Editta Baldini
- Greta Alì
- Alessandro D’Aveni
- Roberta Buosi
- Tiziana Vavalà
- Salvatore Grisanti
- Francesco Passiglia
- Marcello Tiseo
- Alessandro Russo
- Silvia Novello
- Pierluigi Povano
- Elisa Roca
- Paolo Pedrazzoli
- Vieri Scotti
Institutions
- University of Verona (IT)
- University of Parma (IT)
- Agostino Gemelli University Polyclinic (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Ospedale Sacro Cuore Don Calabria (IT)
- Nuovo Ospedale San Giovanni di Dio (IT)
- Ospedale Garibaldi (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Ospedale Humanitas Gradenigo (IT)
- Azienda Sanitaria Locale di Asti (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Azienda Sanitaria Locale Alessandria (IT)
- Policlinico Universitario di Catania (IT)
- Ospedale Vito Fazzi (IT)
- Carlo Forlanini Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Turin (IT)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1016/j.ejca.2025.116191
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00